CA2364630A1 - 50 proteines humaines secretees - Google Patents

50 proteines humaines secretees Download PDF

Info

Publication number
CA2364630A1
CA2364630A1 CA002364630A CA2364630A CA2364630A1 CA 2364630 A1 CA2364630 A1 CA 2364630A1 CA 002364630 A CA002364630 A CA 002364630A CA 2364630 A CA2364630 A CA 2364630A CA 2364630 A1 CA2364630 A1 CA 2364630A1
Authority
CA
Canada
Prior art keywords
seq
sequence
polypeptide
human
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002364630A
Other languages
English (en)
Inventor
Craig A. Rosen
Steven M. Ruben
George Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2364630A1 publication Critical patent/CA2364630A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur de nouvelles protéines humaines sécrétées et sur des acides nucléiques isolés comportant les régions codantes des gènes codant pour lesdites protéines. L'invention porte également sur des vecteurs, cellules hôtes, anticorps, et méthodes de recombinaison servant à produire lesdites protéines humaines sécrétées; elle porte en outre sur des procédés diagnostiques et thérapeutiques permettant de diagnostiquer et traiter les affections liées auxdites nouvelles protéines humaines sécrétées.
CA002364630A 1999-03-12 2000-03-09 50 proteines humaines secretees Abandoned CA2364630A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12409399P 1999-03-12 1999-03-12
US60/124,093 1999-03-12
US16698999P 1999-11-23 1999-11-23
US60/166,989 1999-11-23
PCT/US2000/006012 WO2000055198A1 (fr) 1999-03-12 2000-03-09 50 proteines humaines secretees

Publications (1)

Publication Number Publication Date
CA2364630A1 true CA2364630A1 (fr) 2000-09-21

Family

ID=26822203

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002364630A Abandoned CA2364630A1 (fr) 1999-03-12 2000-03-09 50 proteines humaines secretees

Country Status (5)

Country Link
EP (1) EP1161446A1 (fr)
JP (1) JP2002542766A (fr)
AU (1) AU3517000A (fr)
CA (1) CA2364630A1 (fr)
WO (1) WO2000055198A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259232B1 (en) * 2000-10-27 2007-08-21 Nymox Pharmaceutical Corporation Preferred segments of neural thread protein
EP1373526A4 (fr) * 2001-03-08 2006-01-25 Curagen Corp Polypeptides therapeutiques, les acides nucleiques les codant et leurs procedes d'utilisation
BR0211199A (pt) 2001-07-19 2004-10-26 Nymox Corp Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
EP1847550A3 (fr) * 2001-07-19 2008-01-09 Nymox Corporation Peptides actives dans le traitement des tumeurs et autre conditions requérant la suppression ou la destruction de cellules
US7317077B2 (en) 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
PL1944312T3 (pl) * 2003-03-03 2012-12-31 Dyax Corp Peptydy, które specyficznie wiążą receptor HGF (CMET) i ich zastosowanie
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor

Also Published As

Publication number Publication date
EP1161446A1 (fr) 2001-12-12
JP2002542766A (ja) 2002-12-17
AU3517000A (en) 2000-10-04
WO2000055198A1 (fr) 2000-09-21

Similar Documents

Publication Publication Date Title
CA2344100A1 (fr) 31 proteines humaines secretees
CA2368927A1 (fr) Quarante-cinq proteines humaines secretees
CA2364209A1 (fr) 49 proteines secretees humaines
CA2387696A1 (fr) 48 proteines humaines secretees
CA2364630A1 (fr) 50 proteines humaines secretees
CA2365223A1 (fr) Proteines humaines secretees (46)
CA2368281A1 (fr) 50 proteines humaines secretees
CA2368467A1 (fr) 50 proteines humaines secretees
CA2391364A1 (fr) 47 proteines humaines secretees
CA2361277A1 (fr) Proteines humaines secretees (49)
CA2368302A1 (fr) 49 proteines secretees par un etre humain
CA2364635A1 (fr) 47 proteines humaines secretees
CA2391361A1 (fr) 47 proteines secretees humaines
CA2390946A1 (fr) 49 proteines secretees humaines
CA2368442A1 (fr) 48 proteines humaines secretees
CA2368719A1 (fr) Cinquante proteines humaines secretees
CA2368374A1 (fr) 47 proteines humaines secretees
CA2365247A1 (fr) Proteines humaines secretees (49)
CA2382769A1 (fr) 42 proteines humaines secretees
CA2368916A1 (fr) 49 proteines humaines secretees
CA2368700A1 (fr) Quarante-neuf proteines humaines secretees
WO2000061748A1 (fr) 48 proteines humaines secretees
CA2365238A1 (fr) 48 proteines humaines secretees
CA2366691A1 (fr) 48 proteines humaines secretees
CA2368489A1 (fr) 50 proteines secretees d'origine humaine

Legal Events

Date Code Title Description
FZDE Dead